Stock NUNZ NUNZIA PHARMACEUTICAL COMPANY
Add to a list
To use this feature you must be a member
Log inSign up

Company Nunzia Pharmaceutical Company

Equities

NUNZ

US67097W1027

Pharmaceuticals

Market Closed - OTC Markets
Other stock markets
 08:10:00 2023-12-01 pm EST 		5-day change 1st Jan Change
0.003 USD -.--% Intraday chart for Nunzia Pharmaceutical Company -.--% -.--%
2022 Nunzia Pharmaceutical Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
2022 Nunzia Pharmaceutical Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI

Business Summary

Nunzia Pharmaceutical Corporation is a pharmaceutical company. The Company focuses on development and delivery of pharmaceutical and nutraceutical-based therapies for the behavioral symptoms of Autistic Spectrum of Disorders (ASDs) and related conditions, such as Fragile X syndrome, as well as common anxiety-based disorders. The Company has developed NUNZIA, which is a combination of 16 vitamins, minerals and herbs which directly focuses and targets the hippocampus area of the brain, where all anxiety-based disorders originate.

Managers

Managers TitleAgeSince
Sara Gonzales CEO
 Chief Executive Officer 51 -
Michael Mitsunaga PSD
 President 68 08-12-31
Shujie Cui CTO
 Chief Tech/Sci/R&D Officer 62 19-12-04

Members of the board

Members of the board TitleAgeSince
Michael Mitsunaga PSD
 President 68 08-12-31
Shujie Cui CTO
 Chief Tech/Sci/R&D Officer 62 19-12-04
Sara Gonzales CEO
 Chief Executive Officer 51 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 51,000 0 0 18.04 %
Stock B 1 434,514,578 78,406,578 ( 18.04 %) 0

Company contact information

Nunzia Pharmaceutical Corp.

1627 West 14th Street

90813, Long Beach

+714 609 9117

address Nunzia Pharmaceutical Company(NUNZ)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sector Other Pharmaceuticals

1st Jan change Capi.
NUNZIA PHARMACEUTICAL COMPANY Stock Nunzia Pharmaceutical Company
-.--% 1.3M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+24.60% 672B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+24.08% 550B
JOHNSON & JOHNSON Stock Johnson & Johnson
-5.63% 351B
MERCK & CO., INC. Stock Merck & Co., Inc.
+15.37% 317B
ABBVIE INC. Stock AbbVie Inc.
+7.38% 292B
ASTRAZENECA PLC Stock AstraZeneca PLC
+3.26% 211B
NOVARTIS AG Stock Novartis AG
+0.78% 203B
PFIZER, INC. Stock Pfizer, Inc.
-9.69% 144B
AMGEN INC. Stock Amgen Inc.
-6.63% 141B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. NUNZ Stock
  4. Company Nunzia Pharmaceutical Company